Showing results (31-40 of 414) with videos related to
Sort By:
Pageof 42
Nature Reviews. Rheumatology|December 2, 2025
PD-1, BTLA and TIGIT as therapeutic targets for rheumatic diseaseJuhi R Kuchroo, Naomi Goldman, Arlene H SharpeScience (New York, N.Y.)|June 26, 1987
Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapyA H Sharpe, R Jaenisch, R M RuprechtCirculation Research|November 26, 2008
T-cell costimulation and coinhibition in atherosclerosisIsrael Gotsman, Arlene H Sharpe, Andrew H LichtmanThe Journal of Experimental Medicine|January 20, 1999
B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)D A Mandelbrot, A J McAdam, A H SharpeGerontology|November 18, 2014
Mitochondrial metabolism in T cell activation and senescence: a mini-reviewNoga Ron-Harel, Arlene H Sharpe, Marcia C HaigisCurrent Opinion in Immunology|April 26, 2002
Negative co-receptors on lymphocytesRebecca J Greenwald, Yvette E Latchman, Arlene H SharpeElife|November 10, 2020
The effects of age and systemic metabolism on anti-tumor T cell responsesJefte M Drijvers, Arlene H Sharpe, Marcia C HaigisCurrent Opinion in Immunology|January 13, 2000
The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous systemD E Anderson, A H Sharpe, D A HaflerJournal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formationH J Hernandez, A H Sharpe, M J StadeckerTrends in Immunology|April 8, 2023
Tracking tumor-specific CD8<sup>+</sup> T cell responsesKelly P Burke, Samuel C Markson, Arlene H SharpePageof 42